(Q33347643)

English

Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial

scientific article published on April 24, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12712259

27 December 2023

1 reference

10.1007/S00280-003-0618-8

https://api.crossref.org/works/10.1007/S00280-003-0618-8

27 December 2023

1 reference

10.1007/S00280-003-0618-8

https://api.crossref.org/works/10.1007/S00280-003-0618-8

27 December 2023

author name string

Seiji Niho

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kaoru Kubota

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Koichi Goto

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hironobu Ohmatsu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Taketoshi Matsumoto

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ryutaro Kakinuma

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yutaka Nishiwaki

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12712259

27 December 2023

publication date

24 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00280-003-0618-8.pdf

Portable Document Format

1 reference

10.1007/S00280-003-0618-8

https://api.crossref.org/works/10.1007/S00280-003-0618-8

27 December 2023

http://link.springer.com/article/10.1007/s00280-003-0618-8/fulltext.html

1 reference

10.1007/S00280-003-0618-8

https://api.crossref.org/works/10.1007/S00280-003-0618-8

27 December 2023

http://link.springer.com/content/pdf/10.1007/s00280-003-0618-8

1 reference

10.1007/S00280-003-0618-8

https://api.crossref.org/works/10.1007/S00280-003-0618-8

27 December 2023

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

19-24

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Identifiers

10.1007/S00280-003-0618-8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33347643&oldid=2195268752"